CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would simplify the structure through which its pharmacies get reimbursed for drugs, in a push for more transparency amid scrutiny on surging health care costs.

Under the new model, called CostVantage, the company’s over 9,000 pharmacies will have a fixed markup and fees to define drug cost and related reimbursement with contracted insurers and pharmacy benefit managers (PBMs).